Medicare Enrolled
Dr. Bruce Kriegel, MD
Cardiovascular Disease · Brockton, MA
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kriegel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kriegel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kriegel
Dr. Bruce Kriegel is a cardiovascular disease specialist in Brockton, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kriegel performed 2,777 Medicare services across 1,859 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kriegel received a total of $10,711 from 35 pharmaceutical and/or device companies across 575 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kriegel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 31% volume in MA
$10,711 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,777
Medicare services
Top 31% in MA for cardiovascular disease
1,859
Unique beneficiaries
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~146 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
835 | $92 | $334 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
808 | $11 | $71 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
136 | $123 | $614 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
121 | $70 | $347 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
119 | $16 | $276 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
119 | $10 | $270 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
107 | $17 | $132 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
90 | $58 | $258 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
85 | $6 | $30 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
83 | $22 | $118 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
82 | $52 | $138 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $118 | $509 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
40 | $58 | $215 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $63 | $224 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $76 | $333 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
14 | $15 | $92 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
13 | $15 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.6% high complexity
11.8% medium
75.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,711
Total received (2018-2024)
Avg $1,530/year across 7 years
Top 24% in MA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
575
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,711 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,986
2023
$2,384
2022
$1,737
2021
$400
2020
$533
2019
$2,001
2018
$1,671
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$345
PFIZER INC.
$270
E.R. Squibb & Sons, L.L.C.
$209
Amgen Inc.
$196
Kiniksa Pharmaceuticals International, plc
$188
SCPHARMACEUTICALS INC.
$149
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$102
Boehringer Ingelheim Pharmaceuticals, Inc.
$97
AstraZeneca Pharmaceuticals LP
$80
Janssen Pharmaceuticals, Inc
$75
Lexicon Pharmaceuticals, Inc.
$63
Merck Sharp & Dohme LLC
$54
Novo Nordisk Inc
$30
Esperion Therapeutics, Inc.
$30
Daiichi Sankyo Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$25
Impulse Dynamics (USA) Inc.
$21
Alnylam Pharmaceuticals Inc.
$21
Top 3 companies account for 41.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,004
E.R. Squibb & Sons, L.L.C.
$1,159
Janssen Pharmaceuticals, Inc
$790
PFIZER INC.
$775
Amgen Inc.
$752
AstraZeneca Pharmaceuticals LP
$687
Boehringer Ingelheim Pharmaceuticals, Inc.
$567
Boston Scientific Corporation
$378
Novo Nordisk Inc
$360
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$289
Alnylam Pharmaceuticals Inc.
$286
SCPHARMACEUTICALS INC.
$222
BOSTON SCIENTIFIC CORPORATION
$213
SANOFI-AVENTIS U.S. LLC
$211
Merck Sharp & Dohme LLC
$207
Regeneron Healthcare Solutions, Inc.
$205
GENZYME CORPORATION
$198
Kiniksa Pharmaceuticals International, plc
$188
Gilead Sciences, Inc.
$187
iRhythm Technologies, Inc.
$153
Daiichi Sankyo Inc.
$132
CVRx, Inc.
$104
Kiniksa Pharmaceuticals, Ltd.
$103
Lexicon Pharmaceuticals, Inc.
$80
Amarin Pharma Inc.
$71
Bayer HealthCare Pharmaceuticals Inc.
$63
Bayer Healthcare Pharmaceuticals Inc.
$52
Medtronic Vascular, Inc.
$52
Esperion Therapeutics, Inc.
$50
ABIOMED
$42
Abbott Laboratories
$37
Bardy Diagnostics, Inc.
$35
Philips Electronics North America Corporation
$24
Impulse Dynamics (USA) Inc.
$21
Medtronic, Inc.
$12
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
(5091) Amb Mon & Diag Und · Advisa · Arcalyst · Azure · BRILINTA · Barostim Neo System · CAMZYOS · CHANTIX · CardioMEMS HF System · Carnation Ambulatory Monitor · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · FABRAZYME · FABRY-DISEASE · FARXIGA · FUROSCIX · INJECTAFER · Impella · Inpefa · JARDIANCE · Kerendia · LEQVIO · LOKELMA · LifeVest · MICRA · MULTAQ · NEXLETOL · ONPATTRO · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · Repatha · Reveal LINQ · STIOLTO RESPIMAT · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
575
Per 100K population
108.1
County median income
$109,698
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kriegel is an electrophysiology & cardiac specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kriegel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kriegel performed 835 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kriegel receive payments from pharmaceutical companies?
Yes. Dr. Kriegel received a total of $10,711 from 35 companies across 575 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kriegel's costs compare to other cardiologists in Brockton?
Dr. Kriegel's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kriegel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Brockton
Browse cardiologists in Brockton ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MA
Which MA cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology